Clinical Trial: A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Ocrelizumab in Participants With Relapsing Multiple Sclerosis and Primary Progressive Multiple Sclerosis

U.S., March 20 -- ClinicalTrials.gov registry received information related to the study (NCT07483450) titled 'A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Ocrelizumab in Participants With Relapsing Multiple Sclerosis and Primary Progressive Multiple Sclerosis' on March 16.

Brief Summary: The main purpose of this study is to evaluate the efficacy of ocrelizumab in participants with relapsing multiple sclerosis (RMS) and to characterize the ocrelizumab pharmacodynamic (PD) profile in Chinese participants with primary progressive multiple sclerosis (PPMS).

Study Start Date: July 04, 2025

Study Type: INTERVENTIONAL

Condition: Relapsing Multiple Sclerosis Primary Progressive Multiple Sclerosis

Interve...